BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31784636)

  • 21. Insights into the Activation Mechanism of the ALX/FPR2 Receptor.
    Schmitz Nunes V; Rogério AP; Abrahão O
    J Phys Chem Lett; 2020 Nov; 11(21):8952-8957. PubMed ID: 33030905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Airway lipoxin A4/formyl peptide receptor 2-lipoxin receptor levels in pediatric patients with severe asthma.
    Gagliardo R; Gras D; La Grutta S; Chanez P; Di Sano C; Albano GD; Vachier I; Montalbano AM; Anzalone G; Bonanno A; Riccobono L; Gjomarkaj M; Profita M
    J Allergy Clin Immunol; 2016 Jun; 137(6):1796-1806. PubMed ID: 26971688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
    Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM
    PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental and homeostatic signaling transmitted by the G-protein coupled receptor FPR2.
    Chen K; Gong W; Huang J; Yoshimura T; Ming Wang J
    Int Immunopharmacol; 2023 May; 118():110052. PubMed ID: 37003185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third intracellular receptor loop.
    Forsman H; Bylund J; Oprea TI; Karlsson A; Boulay F; Rabiet MJ; Dahlgren C
    Biochim Biophys Acta; 2013 Aug; 1833(8):1914-23. PubMed ID: 23562731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro-Resolving FPR2 Agonists Regulate NADPH Oxidase-Dependent Phosphorylation of HSP27, OSR1, and MARCKS and Activation of the Respective Upstream Kinases.
    Ammendola R; Parisi M; Esposito G; Cattaneo F
    Antioxidants (Basel); 2021 Jan; 10(1):. PubMed ID: 33477989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The PAR4-derived pepducin P4Pal
    Holdfeldt A; Lind S; Hesse C; Dahlgren C; Forsman H
    Biochem Pharmacol; 2020 Oct; 180():114143. PubMed ID: 32653592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2.
    Khau T; Langenbach SY; Schuliga M; Harris T; Johnstone CN; Anderson RL; Stewart AG
    FASEB J; 2011 Feb; 25(2):483-96. PubMed ID: 20930115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of the N-formyl Peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts.
    Rossi FW; Napolitano F; Pesapane A; Mascolo M; Staibano S; Matucci-Cerinic M; Guiducci S; Ragno P; di Spigna G; Postiglione L; Marone G; Montuori N; de Paulis A
    J Immunol; 2015 Jun; 194(11):5161-73. PubMed ID: 25917089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating neutrophilic inflammation in COPD by targeting ALX/FPR2 resolution pathways.
    Bozinovski S; Anthony D; Anderson GP; Irving LB; Levy BD; Vlahos R
    Pharmacol Ther; 2013 Dec; 140(3):280-9. PubMed ID: 23880288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄.
    Hanson J; Ferreirós N; Pirotte B; Geisslinger G; Offermanns S
    Biochem Pharmacol; 2013 Jun; 85(12):1795-802. PubMed ID: 23643932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-affinity receptor-mediated induction of superoxide by N-formyl-methionyl-leucyl-phenylalanine and WKYMVm in IMR90 human fibroblasts.
    Ammendola R; Russo L; De Felice C; Esposito F; Russo T; Cimino F
    Free Radic Biol Med; 2004 Jan; 36(2):189-200. PubMed ID: 14744631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients.
    Hou XL; Ji CD; Tang J; Wang YX; Xiang DF; Li HQ; Liu WW; Wang JX; Yan HZ; Wang Y; Zhang P; Cui YH; Wang JM; Bian XW; Liu W
    Sci Rep; 2017 Jun; 7(1):3153. PubMed ID: 28600569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pepducin derived from the third intracellular loop of FPR2 is a partial agonist for direct activation of this receptor in neutrophils but a full agonist for cross-talk triggered reactivation of FPR2.
    Gabl M; Winther M; Skovbakke SL; Bylund J; Dahlgren C; Forsman H
    PLoS One; 2014; 9(10):e109516. PubMed ID: 25303226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formyl Peptide Receptor 2 Plays a Deleterious Role During Influenza A Virus Infections.
    Tcherniuk S; Cenac N; Comte M; Frouard J; Errazuriz-Cerda E; Galabov A; Morange PE; Vergnolle N; Si-Tahar M; Alessi MC; Riteau B
    J Infect Dis; 2016 Jul; 214(2):237-47. PubMed ID: 27034344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation.
    Rabiet MJ; Macari L; Dahlgren C; Boulay F
    J Biol Chem; 2011 Jul; 286(30):26718-31. PubMed ID: 21543323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
    Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of novel cyclopentane urea FPR2 agonists and their potential application in the treatment of cardiovascular inflammation.
    Maciuszek M; Ortega-Gomez A; Maas SL; Perretti M; Merritt A; Soehnlein O; Chapman TM
    Eur J Med Chem; 2021 Mar; 214():113194. PubMed ID: 33548634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What formyl peptide receptors, if any, are triggered by compound 43 and lipoxin A4?
    Forsman H; Önnheim K; Andreasson E; Dahlgren C
    Scand J Immunol; 2011 Sep; 74(3):227-234. PubMed ID: 21535079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A neutrophil inhibitory pepducin derived from FPR1 expected to target FPR1 signaling hijacks the closely related FPR2 instead.
    Winther M; Gabl M; Welin A; Dahlgren C; Forsman H
    FEBS Lett; 2015 Jul; 589(15):1832-9. PubMed ID: 26071379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.